Member News

Each year, in an effort to prevent anemia, Danone Indonesia through SGM Eksplor has initiated various educational programs on a national scale and has reached more than 3.5 communities.

This year, Danone Indonesia through SGM Eksplor will carry out a new program initiative "Together Prevent Anemia, Optimize the Cognition of the Advanced Generation" which aims to increase awareness among mothers in Indonesia about the risk of anemia in children under 5 years of age, as well as the importance of consuming foods high in iron. and Vitamin C which comes from animal protein.

Read more

• The agreement emphasizes SHG's commitment to investing in medical technology to give the highest level of service quality and medical outcomes to the patients
• Philips to provide Siloam Hospitals across Indonesia with maintenance and services for all Philips solutions

Jakarta – Siloam Hospitals Group (ticker: SILO.IJ) and Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its strategic multiyear partnership agreement renewal in Jakarta for the next 5 years. The renewal agreement was signed by both representatives, Eric R. Hilman, Integrated Facilities Management Senior GM of Siloam Hospitals Group and Astri Ramayanti Dharmawan, Philips Indonesia President Director. The renewal of this partnership shows SHG’s commitment in investing in the latest medical technology and provide the highest level of service quality and medical outcomes to its patients through collaboration with trusted partner.

According to the Unites States Association of Radiologists, diagnostic testing is central to disease management, with a wide choice of tools and techniques available for the detection, staging and treatment. Diagnostic imaging provides detailed information about structural or disease related changes even in early stages of illness. While there has been progress in diagnostic capabilities in Indonesia, thereare still many people who don’t have access to diagnostics services.

“Access to care is still one of the biggest challenges in Indonesia. The geographical location of Siloam Hospital Group puts us in a strategic position to provide access to advanced diagnostic services. The competence of our medical personnel and the facilities available at Siloam hospitals enable us to provide early detection and support the creation of sustainable treatment services,” said Eric R. Hilman, Integrated Facilities Management Senior GM of Siloam Hospitals Group. “We are excited to extend our partnership with Phillips, one of the largest health technology companies in the world. Through this partnership, we are confident that we will continue optimizing our services through leading technology, equipment, and services that are ready at all times.”

Currently, Siloam has installed Phillips’ medical equipment in all 41 locations which include major equipment such as MRIs, CT-Scans, C-Arms, X-Rays, as well as minor equipment such as patient monitors, Ultrasonography (USG), and many more. Further, Philips will provide maintenance and operational services for all of Philips’ major healthcare technology equipment installed in Siloam’s 34 locations across Indonesia. Not only that, through this partnership, Philips will also provide SHG with convenient access to the latest medical technology and ensure that all spare parts are available across the nation. This will help the hospitals minimize downtime and support SHG in providing high-quality healthcare services to its patients.

“As the health technology company, we are proud to be a trusted partner for Siloam Hospitasl Group in providing word’s class health services through our state-the-art health equipment across Indonesia," said Astri Ramayanti Dharmawan, President Director, Philips Indonesia. "We recognize the criticality of ensuring reliable health equipment availability for hospitals and patients alike. As such, our services place a high emphasis on effective monitoring and maintenance of our equipment to minimize downtime. This not only ensures prompt healthcare services for patients but also enhances the overall efficiency of the healthcare facilities.”

Siloam Hospitals, which was founded in 1996, is Indonesia’s most progressive and innovative healthcare provider, and has set the benchmark for high quality healthcare services in Indonesia. Siloam’s medical team of more than 600 general practitioners, more than 2,700 specialized doctor, more than 8,100 nurses, allied health, technician and support staff, provides healthcare to nearly three million patients annually. In 2007, Siloam Hospitals Lippo Village became the first hospital in Indonesia to receive international accreditation from the USA-based Joint Commission International (JCI), with re-accreditation in 2010. Siloam Hospitals Kebun Jeruk and Siloam Hospitals Denpasar have recently been accredited to JCI as well.

###

About Siloam Hospitals Group

PT Siloam International Hospitals Tbk (“Siloam Hospitals”) is a network of private hospitals in Indonesia committed to providing high quality health services in Indonesia. Starting business in 1996, Siloam Hospitals currently manages and operates 41 hospitals, consisting of 15 hospitals in the Greater Jakarta area and 26 hospitals spread across the islands of Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara and Ambon. Siloam Hospitals Group also operates 66 Siloam Clinics.

Siloam Hospitals' vision is to provide international quality healthcare and reach all levels of society on a national scale based on Godly compassion which is the basis for Siloam Hospitals to respond to the dynamic social transformation in Indonesia. Siloam Hospitals' mission is to be the trusted choice for world-class holistic healthcare, health education and research.

Siloam Hospitals is the pioneer of Joint Commission International (JCI) accreditation for hospitals in Indonesia. JCI is an international accreditation agency based in the United States that focuses on improving the quality of health care and patient safety.

For more information about Siloam Hospitals, visit www.siloamhospitals.com.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 71,500 employees with sales and services in more than 100 countries.

News about Philips can be found at www.philips.com/newscenter.